This HTML5 document contains 184 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n11http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n12https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q40277377
rdf:type
wikibase:Item
schema:description
2006年論文 vědecký článek artigo científico article scientifique teaduslik artikkel مقالة علمية نشرت في 20 أكتوبر 2006 articol științific vitskapeleg artikkel bilimsel makale 2006年论文 2006年論文 articolo scientifico scientific article published on 20 October 2006 article scientific artigo científico научни чланак 2006年论文 2006年論文 мақолаи илмӣ tieteellinen artikkeli 2006 nî lūn-bûn 2006年论文 vitenskapelig artikkel научна статия tudományos cikk artículu científicu espublizáu en 2006 artykuł naukowy научни чланак 2006年論文 bài báo khoa học מאמר מדעי artigo científico บทความทางวิทยาศาสตร์ artikulong pang-agham ২০ অক্টোবর ২০০৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ wetenschappelijk artikel vetenskaplig artikel scientific article published on 20 October 2006 სამეცნიერო სტატია наукова стаття, опублікована в жовтні 2006 videnskabelig artikel 2006年论文 scienca artikolo επιστημονικό άρθρο scientific article published on 20 October 2006 article científic 2006年论文 artikel ilmiah 2006年論文 wissenschaftlicher Artikel vedecký článok artículo científico publicado en 2006 2006년 논문 2006年论文 2006 ഒക്ടോബര്‍ 20 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം 2006年の論文 научная статья naučni članak artikull shkencor
p:P577
wds:Q40277377-6BEEF13C-7630-46F6-ACF1-F2250A915DC0
wdt:P577
2006-10-20T00:00:00Z
p:P2888
wds:Q40277377-747A443E-A7BF-4334-9380-CFADC5EC2C90
wdt:P2888
n12:s10637-006-9017-4
p:P2860
wds:Q40277377-D7B15C19-63BF-4F4E-85C1-A8D0084B1021 wds:Q40277377-683D9B53-7488-483D-B76A-3694E4D6EC34 wds:Q40277377-714572C1-8F41-4FE6-AE36-1AC4A7738157 wds:Q40277377-750CC810-71DD-4B55-9F2D-62F66586C80C wds:Q40277377-75110591-0B67-4646-B276-EE34B4917EB0 wds:Q40277377-34DF611C-BDA1-4A41-BD28-B4A9B78E6B75 wds:Q40277377-42C3FE07-F1A3-48DF-97AE-887376E238E7 wds:Q40277377-59E8F092-59CE-4087-86CB-D900DD8771C2 wds:Q40277377-6480D550-65E7-45FC-BD58-A6A06A5F0368 wds:Q40277377-66B3FB2B-CD2F-4041-AD2F-F4290284F067 wds:Q40277377-907863DD-A7D4-4E6C-8889-1C55A57E8B53 wds:Q40277377-9184C1E1-5843-4FB5-A2A0-49235B28A411 wds:Q40277377-940CC9D6-78A8-44BB-BB92-AF8037AD94A5 wds:Q40277377-952398E2-1F62-47A3-8DFC-025AE19DE60A wds:Q40277377-96B685E5-DA5E-4CFE-8FE9-33B1226030D1 wds:Q40277377-97E8FC4C-2203-4ED1-96C3-ACC833273E9B wds:Q40277377-992DA820-06DA-48A0-AAF0-18D5DA97507D wds:Q40277377-A21897C7-9759-41D8-BD0F-50B439909587 wds:Q40277377-77353F63-3C3E-487C-A948-FD787650DDFB wds:Q40277377-7DEA61D6-A2F7-4D86-B795-B4C24FEB0F75 wds:Q40277377-86BC6433-DC57-49A6-BB99-C50FF524C73C wds:Q40277377-8774AC6A-3554-4C82-910E-A7A0CAA12EDC wds:Q40277377-8F42BD11-6697-47F3-B92E-0395951DD523 wds:Q40277377-22464020-B8AA-4A12-AB59-50056E45BB7C wds:Q40277377-226A80C0-7F3A-43F1-AF57-03656F7D3AA8 wds:Q40277377-23C9978E-E104-4448-862E-5A8D04BD345D wds:Q40277377-2486B8BE-D1DF-487A-82D4-B3927972EB3B wds:Q40277377-28CF74CC-FCBE-4C4F-ADB1-34743BF8C75F wds:Q40277377-0125A6DF-9DDF-406F-A1BF-23235AA5348C wds:Q40277377-13B18092-F091-410A-AF7E-AC9116C9BE76 wds:Q40277377-140437B2-F345-4081-86C8-04A283780AD1 wds:Q40277377-15B8D423-DB74-4535-BE57-81FF72850F91 wds:Q40277377-1975C360-477D-4EFC-B0A7-E2FA02B00E48 wds:Q40277377-DF19DEB9-CC4A-4A8A-9068-509E741563A3 wds:Q40277377-F010EAF2-686E-4A77-B801-5D53AD4946A6 wds:Q40277377-B6DFAA18-5CD3-4203-B3F1-4B9FD41B23AD wds:Q40277377-C3F95529-7DD3-426A-89DE-462C161ED61D wds:Q40277377-C465FC57-E905-4CA9-B74C-ED05D13D5EB2 wds:Q40277377-C6D88FD4-3F7D-4C4A-8FA8-870593963EB9 wds:Q40277377-CD67DCB6-D1F0-4407-B712-5B075B5AB138
wdt:P2860
wd:Q28268241 wd:Q41740731 wd:Q46853686 wd:Q74306461 wd:Q74006277 wd:Q54117344 wd:Q77556607 wd:Q48145206 wd:Q74619579 wd:Q46455506 wd:Q40840044 wd:Q48014644 wd:Q40511355 wd:Q71840620 wd:Q35800437 wd:Q43629728 wd:Q54292491 wd:Q33448329 wd:Q41370607 wd:Q41288491 wd:Q45748699 wd:Q40584819 wd:Q33355508 wd:Q40497919 wd:Q77556982 wd:Q41661829 wd:Q41632747 wd:Q40805189 wd:Q43763013 wd:Q29400070 wd:Q72096690 wd:Q48109652 wd:Q72295048 wd:Q50507906 wd:Q41603068 wd:Q43651739 wd:Q43698918 wd:Q40934896 wd:Q71871976 wd:Q36965965
p:P2093
wds:Q40277377-8D9FB66A-CE11-4A87-BA50-D2F3612600A0 wds:Q40277377-8C915C38-B063-4FF6-A307-7F6C5F40576E wds:Q40277377-85B0C206-1406-44EB-8A96-2D222FFBC3FB wds:Q40277377-5A3D9859-8F9E-4610-AEA9-4C4705E33A97 wds:Q40277377-D267A255-1DFA-49B3-AB55-C5CC7FC9AE34
wdt:P2093
David R Spriggs Jon Olson William P Tong Charles W Young Mark G Malkin
rdfs:label
Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors
skos:prefLabel
Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors
schema:name
Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors
p:P50
wds:Q40277377-69E76948-2D9C-4F11-87C2-8AAF80C3F803
wdt:P50
wd:Q37391549
p:P1476
wds:Q40277377-1BF5120E-AE53-4784-9B6B-4640A258732C
wdt:P1476
Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors
p:P304
wds:Q40277377-B871FBE0-7F06-40F6-9B78-DD415A4FAE93
wdt:P304
131-138
p:P31
wds:Q40277377-38493A60-2BA1-418D-A445-29BF4A247953
wdt:P31
wd:Q13442814
p:P921
wds:Q40277377-F2367739-B293-4EEC-BBDD-C43F6E019DC8
wdt:P921
wd:Q5452194
p:P698
wds:Q40277377-17CA8512-C865-4F3D-AE93-8682BA552548
wdtn:P698
n13:17053987
wdt:P698
17053987
p:P1433
wds:Q40277377-319962FB-10C9-43B9-919D-73D3BD1D8B60
wdt:P1433
wd:Q2312231
p:P433
wds:Q40277377-F25E583D-CCDB-4247-915D-495AD72B1389
p:P478
wds:Q40277377-6A52B774-269E-4D92-ABCE-5E77A4B15332
wdt:P433
2
wdt:P478
25
p:P356
wds:Q40277377-1BB5D52B-485D-4B0F-9129-BFAE63CC412C
wdtn:P356
n11:S10637-006-9017-4
wdt:P356
10.1007/S10637-006-9017-4
p:P6179
wds:Q40277377-3363C52C-527C-4F77-9035-3AFD664760EA
wdt:P6179
1018485532